Antibiotic-resistant bacterial infections are a growing. Worse yet, the pipeline of new antibiotic drugs in development are few and far between. It’s been several years since the U.S. Food and Drug Administration (FDA) approved a new antibiotic. The FDA recently declined to approve two new applications for drugs to treat urinary tract infections (sulopenem and tebipenem). The agency wants more data on the efficacy compared to drugs currently on the market. It’s not likely to get better anytime soon.
Category: Health Economics & Costs
Diet or Exercise: It Not Either / Or, It’s Both
Do you like to dine on a meal of McDonald’s Big Macs and supersized fries? Maybe you like desserts like fried pies a little too much. Perhaps you think that jogging to McDonalds and back after eating a Big Mac will atone for your poor diet. According to experts it won’t.
Thursday Links
- A death row inmate wants to donate a kidney. Texas won’t let him.
- How well does Paxlovid really work?
- Casey Mulligan and Joe Grogan defend PBMs. (WSJ)
- More on surprise bills: they occur in one in five emergency room visits and up to one in six in-network hospital stays.
- The Baduy, an indigenous group in Indonesia, have rejected vaccinations. Their Covid death toll: zero. (NYT)
- More on circadian rhythms: mice live longer if they eat on the right time schedule. (DMN)
Wednesday Links
- How an economist thinks about abortion. Well, at least one economist.
- Why is Google investing in health care?
- Is developing Covid vaccines a profitable venture for drug companies? “The answer is a resounding ‘no’. In fact, in most cases, developing mRNA vaccines for a portfolio of emerging diseases would be a money loser.”
- How common is prior authorization?
- Price controls on insulin: The (intended?) result will that be that consumers will pay more, diabetes complications will get worse, and incumbent manufacturers will make more money.
- Almost a quarter of Americans over the age of 18 are now medicated for one or more of these conditions. (HT: Tyler)
- Canada’s health care providers say their system is “collapsing.”